Cardiovascular Services

NAH is recruiting for active clinical research studies

Active studies related to heart disease or diabetes

If you have heart disease and/or diabetes, you may be eligible for one of the following research studies.

CLEAR Outcomes

A multicenter study to assess the effects of bempedoic acid on the occurrence of major cardiovascular events in patients with, or at high risk for, cardiovascular disease who are statin-intolerant.

CLEAR Outcomes Patient Brochure

Active studies related to congestive heart failure

If you have been diagnosed with congestive heart failure and have known or unknown evidence of iron deficiency, you may be eligible for:


This study investigates the efficacy and safety of injectable iron, or ferric carboxymaltose, as a treatment for heart failure with iron deficiency


This heart failure clinical study focuses on care optimization through patient and hospital engagement.

Active studies in follow up (no longer recruiting)

Dal-GenE trial

This is a clinical research study evaluating the effects of an investigational drug on reducing the risk of future cardiac/heart events.

Clear Harmony OLE

This is a randomized, double-blind, placebo-controlled, multicenter long-term safety and tolerability study of ETC-1002 in patients with hyperlipidemia at high cardiovascular risk who are not adequately controlled by their lipid-modifying therapy.

Registries in follow-up (no longer recruiting)

  • None at this time

Completed studies (no longer recruiting or in follow-up)

  • Cardiovascular Inflammation Reduction Trial (CIRT)
  • Clear Harmony
  • Clear Wisdom

Interested in participating?